PIRTOBRUTINIB (LOXO-305), A NEXT GENERATION HIGHLY SELECTIVE NON-COVALENT BTK INHIBITOR IN PREVIOUSLY TREATED RICHTER TRANSFORMATION: RESULTS FROM THE PHASE 1/2 BRUIN STUDY